Digiliti Money Group (OTCMKTS: DGLT) and Vermillion (NASDAQ:VRML) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

Analyst Ratings

This is a summary of recent recommendations and price targets for Digiliti Money Group and Vermillion, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Digiliti Money Group 0 0 1 0 3.00
Vermillion 0 0 1 0 3.00

Digiliti Money Group currently has a consensus price target of $6.00, indicating a potential upside of 3,650.00%. Vermillion has a consensus price target of $2.25, indicating a potential upside of 13.64%. Given Digiliti Money Group’s higher possible upside, equities research analysts plainly believe Digiliti Money Group is more favorable than Vermillion.

Profitability

This table compares Digiliti Money Group and Vermillion’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Digiliti Money Group -147.73% N/A -199.21%
Vermillion -332.10% -200.44% -114.50%

Volatility and Risk

Digiliti Money Group has a beta of -0.66, suggesting that its stock price is 166% less volatile than the S&P 500. Comparatively, Vermillion has a beta of 2.37, suggesting that its stock price is 137% more volatile than the S&P 500.

Valuation and Earnings

This table compares Digiliti Money Group and Vermillion’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Digiliti Money Group $7.97 million 0.20 -$15.16 million N/A N/A
Vermillion $2.64 million 45.00 -$14.96 million ($0.20) -9.90

Vermillion has lower revenue, but higher earnings than Digiliti Money Group.

Institutional & Insider Ownership

11.3% of Digiliti Money Group shares are held by institutional investors. Comparatively, 34.9% of Vermillion shares are held by institutional investors. 50.9% of Digiliti Money Group shares are held by company insiders. Comparatively, 3.7% of Vermillion shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Digiliti Money Group Company Profile

Digiliti Money Group, Inc., formerly Digiliti Money, Inc., is a technology solutions and services provider to the financial services industry. The Company’s solutions and services enable its clients, such as banks, credit unions and alternative financial services providers (AFS) to offer their customers remote deposit capture (RDC) and prepaid mobile money technologies and related services. It offers RDC products for businesses and consumers; mobile money management products for consumers, and training and support services for its financial services industry customers. The RDC products are offered to banks and credit unions in the United States, Canada and Latin America. Its mobile money management products are offered to traditional financial institutions (FIs), as well as AFS in the United States, Canada and Latin America. These FIs and AFS providers include banks, credit unions, prepaid card issuers, check cashers and payday lenders.

Vermillion Company Profile

Vermillion, Inc. is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. It sells OVA1 risk of malignancy test for pelvic mass disease (OVA1). OVA1 is a blood test designed to, in addition to a physician’s clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor prior to planned surgery. It developed OVA1 through pre-clinical studies in collaboration with various academic medical centers encompassing over 2,500 clinical samples. OVA1 is validated in a multi-center clinical trial encompassing approximately 30 sites reflective of the diverse nature of the clinical centers, at which ovarian adnexal masses are evaluated. Its ASPiRA LABS is a laboratory that provides diagnostic services using a biomarker-based diagnostic algorithm to inform clinical decision making and personalized treatment plans.

Receive News & Ratings for Digiliti Money Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digiliti Money Group and related companies with MarketBeat.com's FREE daily email newsletter.